Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v8-EN | Version v5-FR | |
---|---|---|
Language | English | French |
Date Updated | 2022-01-04 | 2021-08-10 |
Drug Identification Number | 02245464 | 02245464 |
Brand name | BLES | BLES |
Common or Proper name | bovine lipid extract surfactant | bovine lipid extract surfactant |
Company Name | BLES BIOCHEMICALS INC | BLES BIOCHEMICALS INC |
Ingredients | SURFACTANT-ASSOCIATED PROTEINS SP-B AND SP-C PHOSPHOLIPID | SURFACTANT-ASSOCIATED PROTEINS SP-B AND SP-C PHOSPHOLIPID |
Strength(s) | 500MCG 27MG | 500MCG 27MG |
Dosage form(s) | SUSPENSION | SUSPENSION |
Route of administration | INTRATRACHEAL INTRATRACHEAL | INTRATRACHEAL INTRATRACHEAL |
Packaging size | 4 mL | 4 mL |
ATC code | R07AA | R07AA |
ATC description | OTHER RESPIRATORY SYSTEM PRODUCTS | OTHER RESPIRATORY SYSTEM PRODUCTS |
Reason for discontinuation | Business reasons | Business reasons |
Anticipated discontinuation date | 2021-12-31 | 2021-12-31 |
Actual discontinuation date | 2021-12-31 | |
Remaining supply date | 2021-12-31 | 2021-12-31 |
Discontinuation status | Discontinued | To be discontinued |
Discontinuation decision reversal | no | no |
Tier 3 Status | No | No |
Information on remaining supply | ||
Company comments | 3 mL and 5 mL sizes remain available | 3 mL and 5 mL sizes remain available |
Health Canada comments |